How keytruda.com’s landing page get definite success?|LandingSpy

During the entire advertising process, the landing page is the last and most important part of promoting user conversion. Normally, we will change a certain version of the landing page, change a few small elements, and finally form several similar landing pages for A/B testing.

Through LandingSpy, we can track the landing page of competitors, including their landing page copy, landing page image, and landing page advertising time, and other important information. By analyzing the competitor’s landing page, we can know more clearly how to develop our own advertising strategy.

keytruda.com has set up a total of 14 landing pages recently. The advertising platform is Facebook, and the advertising time is mostly concentrated on 2020/02/04~2020/06/16.



Advertising Landing Page Performance


  Title Date Duration Days Networks Country
1 Register for the KEY+YOU Patient Support Program for KEYTRUDA® (pembrolizumab) 2020/02/04~2020/06/16 132 Facebook N/A
2 Clinical Trial Results in Some Patients With High-risk Non-Muscle Invasive Bladder Cancer (NMIBC) | Patients 2020/02/14~2020/05/30 106 Facebook N/A
3 Clinical Trial Results in Head and Neck Squamous Cell Cancer | Patients 2020/04/01~2020/06/01 61 Facebook N/A
4 Melanoma Therapies With KEYTRUDA® (pembrolizumab): Metastatic Melanoma, Adjuvant Therapy | Patients 2020/04/01~2020/05/18 47 Facebook N/A
5 N/A N/A N/A N/A N/A



Top 3 Landing pages Free Analytics


1.Top 1 Landing page of keytruda.com


Title:Register for the KEY+YOU Patient Support Program for KEYTRUDA® (pembrolizumab)

Description:This program is designed to offer educational resources to help with the practical and emotional challenges of cancer. Patients prescribed KEYTRUDA® (pembrolizumab) for an approved indication can receive 24/7 phone support, e-mails, and online activities.

Type:Other


2.Top 2 Landing page of keytruda.com


Title:Clinical Trial Results in Some Patients With High-risk Non-Muscle Invasive Bladder Cancer (NMIBC) | Patients

Description:See the results from a clinical trial that included certain patients who received KEYTRUDA® (pembrolizumab) for high-risk non-muscle invasive bladder cancer (NMIBC).

Type:Other


3.Top 3 Landing page of keytruda.com


Title:Clinical Trial Results in Head and Neck Squamous Cell Cancer | Patients

Description:Review the results from a clinical trial that included patients who received KEYTRUDA® (pembrolizumab) for head and neck squamous cell cancer.

Type:Other